Nektar Therapeutics stock price
넥타 테라퓨틱스NASDAQ:NKTR · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Nektar Therapeutics last closed at $43.58 (-7.26%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -9.2×. Its overall grade ranks 384 of 739 stocks in Healthcare.
About this company
Nektar Therapeutics last closed at $43.58 (-7.26%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 384/739
Valuation grade A-
Related stocks
- Bristol-Myers SquibbCustomer
Nektar의 면역항암제 후보 NKTR-214(아네토키맙 계열) 공동개발 이력과 파트너 관계
- Eli LillyCustomer
Nektar와 과거 면역질환·신약 후보 공동개발 협력 이력
- AmgenCustomer
Nektar의 약물전달/제형 플랫폼 및 공동개발 협력 이력
About Nektar Therapeutics
- What technical signals does Nektar Therapeutics (NKTR) have?
- Nektar Therapeutics current technical signals: no active technical signal.
- Is Nektar Therapeutics a cup-and-handle pattern?
- No. Nektar Therapeutics has no valid Cup signal right now.
- What published figures are available for Nektar Therapeutics?
- Market cap: $886.49M. Trailing 12 months PER: -9.2×. Latest quarter PBR: 1.60×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Nektar Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).